Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
New AMYPAD paper published in Brain Communications
New AMYPAD paper published in Brain Communications 30 Jun 2022 In this work, authors used data from three parent cohorts involved in the AMYPAD......
The baseline paper of the AMYPAD Diagnostic Study has been published
The baseline paper of the AMYPAD Diagnostic Study has been published 21 Jun 2022 The aim of this article is to discuss the implemented enrollment strategies and describe the baseline features of the AMYPAD DPMS participants......
AMYPAD presents at SNMMI 2022
AMYPAD presents at SNMMI 2022 14 Jun 2022 Merle Hoenig presented an oral talk at the SNMMI Annual Meeting......
Recruitment status (as 30 April 2022)
Recruitment status (as 30 April 2022)